» Publications

SCI-SSCI or SCI Expanded Articles

Uyanık V, Tuğlu C, , Gorgulu Y, et al. “Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment” PSYCHIATRY RESEARCH, 228, 386-392 (2015)

9
ATIF

ATIFLAR

Xu, FM; Wang, XB; (...); Wang, YM. Analysis of complete blood count and derived inflammatory indicators for bipolar disorder patients with different states. FRONTIERS IN PSYCHIATRY (July 2023)
Kafami, L; Assadiasl, S; (...); Noorbala, AA. Evaluation of Inflammatory Markers in Patients with Depressed Episodes in Major Depressive Disorder and Bipolar Disorder before and after Treatment. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY
Shao, SY; Zou, Y; (...); Goldstein, B.Higher Levels of C-reactive Protein Are Associated With Higher Cortical Surface Area and Lower Cortical Thickness in Youth With Bipolar Disorder. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Zhang, XM; Li, XY; (...); Zhang, FF. C-Reactive Protein in Bipolar Disorder and Unipolar Depression 210 (7) , pp.510-514 (June 2022)
Zou, Y; Grigorian, A; (...); Goldstein, BI. C-reactive protein among symptomatic youth with bipolar disorder 36 (5) , pp.645-652 (May 2022)
Jacoby AS, Munkholm K, Vinberg M, Pedersen BK, Kessing LV. “Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study”, J Affect Disord, 197:167-74 (2016)
Mert DG, Terzi H. "Mean platelet volume in bipolar disorder: the search for an ideal biomarker" NEUROPSYCHIATRIC DISEASE AND TREATMENT, 16;12:2057-62 (2016)
Balukova SM, Haarman BC, Riemersma-van der Lek RF, Schoevers RA. "Does CRP predict outcome in bipolar disorder in regular outpatient care?" INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, doi: 10.1186/s40345-016-0055-3 (2016)
van den Ameele S, van Diermen L, Staels W, et al. "The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic reviewé JOURNAL OF AFFECTIVE DISORDERS, 203, 364-73 (2016)

Adult Attention Deficit Hyperactivity Disorder: Neurobiology, Diagnostic Problems and Clinical Features. Cengiz Tuğlu , Özlem Öztürk Şahin. CURRENT APPROACHES IN PSYCHIATRY 2010;2(1):75116

2
ATIF

Assessment of alterations in regional cerebral blood flow in patients with hypothyroidism due to Hashimoto’xxs thyroiditis. KAYA MERYEM,ÇERMİK TEVFİK FİKRET,TUĞLU CENGİZ. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, Jan 2007 (January 2007)

2
ATIF

Tamam, L (Tamam, Lut) ; Tuglu, C (Tuglu, Cengiz) ; Karatas, G (Karatas, Gonca) ; Ozcan, S (Ozcan, Sevilay). Adult attention-deficit hyperactivity disorder in patients with bipolar I disorder in remission: Preliminary study. PSYCHIATRY AND CLINICAL NEUROSCIENCES (August 2006)

2
ATIF

TUĞLU CENGİZ,Erdoğan Esin,ABAY ERCAN. Delirium and extrapyramidal symptoms due to a lithium olanzapine combination therapy A case report. J Korean Med Sci . pp 765-771 Jun 2005 (June 2005)

2
ATIF

Akturk, Z; Dagdeviren, N; Ture, M; Tuglu. Birinci basamak icin Beck Depresyon Tarama Olcegi'nin Turkce ceviriminin gecerlik ve guvenirligi. C. Turkiye Aile Hekimligi Dergisi. 117-22,2005.

1
ATIF

Cotard's syndrome with schizophreniform disorder can be successfully treated with electroconvulsive therapy: case report. Caliyurt, O (Caliyurt, O) ; Vardar, E (Vardar, E) ; Tuglu, C (Tuglu, C). JOURNAL OF PSYCHIATRY & NEUROSCIENCE, Volume29 Issue2, Page138-141, MAR 2004 (March 2004)

1
ATIF

Vardar E, Caliyurt, O, Arikan E, Tuglu C. “Sleep quality and psychopathological features in obese binge eaters” STRESS AND HEALTH, 20, 35-42 (2004)

5
ATIF

Celik Y, Erdogan E, Tuglu C, Utku U. “Post-stroke mania in late life due to right temporoparietal infarction” PSYCHIATRY AND CLINICAL NEUROSCIENCES, 58(4):446-7 (2004)

2
ATIF

Aortic aneurysm and electroconvulsive therapy in elderly depressive patient. Caliyurt, O; Tuglu, C and Vardar, E. JOURNAL OF ECT, Dec 2003 | 19 (4) , pp.242-244 (December 2003)

1
ATIF

Tuglu, C; Kara, SH .Depression, cytokines and immune sys-tem. B CLIN PSYCHOPHARMAC, 13, 42-150, 2003.
1
ATIF
ATIFLAR
- C-Reactive protein and Neutrophil leucocyte ratio in Depressive disorder: a hospital based cross sectional study. Uma, BM; Bondade, S and Rao, SPK. ARCHIVES OF PSYCHIATRY AND PSYCHOTHERAPY, 24 (2) , pp.13-20, 2022.

Tuğlu C, Kara SH, Çalıyurt O, Vardar E, Abay E. “Increased Serum Tumor Necrosis Factor-Alpha Levels and Treatment Response in Major Depressive Disorder” Psychopharmacology(Berl), 170, 429-33 (2003).

25
ATIF

ATIFLAR

Otsuka, N; Takaesu, Y; (...); Kondo, T. Elevated Brain-Derived Neurotrophic Factor Levels During Depressive Mixed States. PSYCHIATRY INVESTIGATION (November 2023)
Akter, S; Emon, FA; (...); Islam, MR. Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study. BMC PSYCHIATRY (November 2023)
Nayem, J; Sarker, R; (...); Mahmud, ZA.Altered serum TNF-α and MCP-4 levels are associated with the pathophysiology of major depressive disorder: A case-control study results.PLOS ONE (November 2023)
Arockiaraj, N; Gupta, R; (...); Bhatia, MS. Sertraline with desvenlafaxine and sertraline with mirtazapine as treatment initiation in MDD patients with moderate to severe depression and effect on inflammatory markers. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (November 2023)
Islam, MR; Sohan, M; (...); Shahriar, M. Evaluation of inflammatory cytokines in drug-naïve major depressive disorder: A systematic review and meta-analysis. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (August 2023)
Zhang, YX; Chen, JX; (...); Xu, QD. Combined influence of depression and low-grade inflammation on mortality in peritoneal dialysis patients. BMC NEPHROLOGY (August 2023)
Esalatmanesh, S; Kahani, L and Akhondzadeh, S. Celecoxib in Treatment of Postpartum Depression: A Case Report. ARCHIVES OF IRANIAN MEDICINE (July 2023)
Guo, J; Fang, M; (...); Zeng, P. Mechanistic insights into the anti-depressant effect of curcumin based on network pharmacology and experimental validation. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (July 2023)
Esalatmanesh, S; Kashani, L; (...); Akhondzadeh, S. Efficacy and safety of celecoxib for treatment of mild to moderate postpartum depression: a randomized, double-blind, placebo-controlled trial. ARCHIVES OF GYNECOLOGY AND OBSTETRICS (April 2023)
Breit, S; Mazza, E; (...); Benedetti, F. White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD. JOURNAL OF PSYCHIATRIC RESEARCH (March 2023)
Ibrahim, IM; Alsieni, M; (...); Kumar, V. Comparative evaluation of natural neuroprotectives and their combinations on chronic immobilization stress-induced depression in experimental mice. BIOTECH
Hartmann, A; Vila-Verde, C; (...); Lisboa, SF. The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol. CURRENT NEUROPHARMACOLOGY
Tsai, ST; Nithiyanantham, S; (...); Su, KP. Anti-Inflammatory Effect of Traditional Chinese Medicine on the Concept of Mind-Body Interface. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY
Orsolini, L; Pompili, S and Volpe, U. C-Reactive Protein (CRP): A Potent Inflammation Biomarker in Psychiatric Disorders. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY
Elgellaie, A; Thomas, SJ; (...); Larkin, T. Pro-inflammatory cytokines IL-1α, IL-6 and TNF-α in major depressive disorder: Sex-specific associations with psychological symptoms. EUROPEAN JOURNAL OF NEUROSCIENCE
Stress- and drug-induced neuroimmune signaling as a therapeutic target for comorbid anxiety and substance use disorders. Smiley, CE and Wood, SK. PHARMACOLOGY & THERAPEUTICS Nov 2022 | Jun 2022 (Early Access) | 239 (November 2022)
Exploring the role of biologics in depression. Rani, T; Behl, T; (...); Bungau, SG Oct 2022 | Jul 2022 (Early Access) 98 (October 2022)
The Role of Interleukins in the Pathogenesis of Dermatological Immune-Mediated Diseases Turchin, I and Bourcier, M Oct 2022 | Aug 2022 (Early Access) | 39 (10) , pp.4474-4508 (October 2022)
Screening for depressive symptoms in patients with rheumatoid arthritis: relationship with pain severity, disease activity, and sleep quality. Azzam, AI; Lamlom, M and Khalifa, AM 29 (1) (September 2022)
Stress and Inflammatory Bowel Disease: Clear Mind, Happy Colon. De Sousa, JFM; Paghdar, S; (...); Tsouklidis, N May 15 2022 | 14 (5) (May 2022)
Risk factors for low back pain outcome: Does it matter when they are measured? Klyne, DM; Hall, LM; (...); Hodges, PW Apr 2022 | Feb 2022 (Early Access) | 26 (4) , pp.835-854 (April 2022)
Suicide Risk in Rheumatoid Arthritis Patients is Associated With Suboptimal Vitamin D Levels Espinoza, IC; Chavarria-Avila, E; (...); Vazquez-Del Mercado, M Apr 2022 | 28 (3) , pp.137-142 (April 2022)
C-Reactive Protein as a Biomarker for Major Depressive Disorder? Orsolini, L; Pompili, S; (...); Volpe, U Feb 2022 | 23 (3) (February 2022)
Tryptophan into Kynurenine in Patients with Major Depression and Suicidal Behavior. Messaoud, A; Rym, M; (...); Comai, S 2022 | 22 (25) , pp.2119- 2125
Tuğlu C, Kara SH, Çalıyurt O, Vardar E, Abay E. “Increased Serum Tumor Necrosis Factor-Alpha Levels and Treatment Response in Major Depressive Disorder” Psychopharmacology(Berl), 170, 429-33 (2003).

Doctoral Dissertations Advised

Dr. Mert Özkan Bipolar bozukluk tanılı hastaların ötimik dönemlerindeki eşik altı anksiyete belirtilerinin yaşam kalitesi ve işlevsellik üzerine etkisi

Referee Positions

Doç. Dr. Mehmet Bülent Sönmez, Profesörlük atanma (January 2023)
Doç. Dr. Yasemin Görgülü / Profesörlük Atanma